Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes

Thirunavukkarasu Sathish, Robyn Tapp, Mark E. Cooper, Paul Zimmet

Research output: Contribution to journalComment/debate

Abstract

The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly evolving worldwide and is now face-to-face with another major pandemic ― diabetes mellitus.
Original languageEnglish
Pages (from-to)(In-press)
JournalDiabetes and metabolism
Volume(In-press)
DOIs
Publication statusE-pub ahead of print - 28 Oct 2020

Keywords

  • COVID-19
  • Coronavirus
  • Incident diabetes
  • Inflammation
  • Insulin resistance
  • Insulin secretion
  • New-onset diabetes
  • Metabolism
  • Type 1 diabetes
  • Type 2 diabetes

Fingerprint Dive into the research topics of 'Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes'. Together they form a unique fingerprint.

Cite this